| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Allogene Therapeutics (ALLO) | Goldman Sachs/ J.P. Morgan/ Cowen/ Jefferies | $100.00 | n.a. | |||
| Anaplan (PLAN) | Goldman Sachs/ Morgan Stanley/ Barclays | $100.00 | n.a. | |||
| ChaSerg Technology Acquisition (CTAC.U) (u) | Cantor | 20.00 | $10.00 | $10.00 | $200.00 | n.a. |
| Collier Creek Holdings (CCH.U) (u) | Citigroup/ Credit Suisse/ BofA Merrill Lynch | 35.00 | $10.00 | $10.00 | $350.00 | n.a. |
| EdtechX Holdings Acquisition (EDTXU) (u) | Chardan/ I-Bankers | 5.50 | $14.00 | $16.00 | $82.50 | n.a. |
| Osmotica Pharmaceuticals plc (OSMT) | Jefferies/ Barclays/ RBC Capital Markets | $100.00 | n.a. | |||
| Studio City International Holdings (MSC) | Deutsche Bank Securities/ Credit Suisse/ Morgan Stanley | $115.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| Navios Maritime Containers L.P. (NMCI) | J.P. Morgan/ BofA Merrill Lynch/ Citigroup/ Clarksons Platou Securities | 5.26 | $18.00 | $20.00 | $100.00 | N/C |
| N/C = No Call – Stock is traded on the Norwegian Over-The-Counter System since June 12, 2017 | ||||||
| Withdrawn | ||||||
| Adaptive Insights (ADIN) | Morgan Stanley/ BoA Merrill Lynch/ Jefferies/ RBC Capital Markets | 8.20 | $13.00 | $15.00 | $114.80 | S/O |
| Bicapital (BICA) | BofA Merrill Lynch/ Citigroup/ J.P. Morgan | $345.00 | S/O | |||
| Product Shipping Limited (PROS) | Morgan Stanley | $100.00 | S/O | |||
| New Terms | ||||||
| Arco Platform (ARCE) | Goldman Sachs/ Morgan Stanley/ Itaú BBA/ BofA Merrill Lynch | 11.11 | $15.50 | $17.50 | $183.33 | S/O |
| Arvinas (ARVN) | Goldman Sachs/ Citigroup/ Piper Jaffray | 6.67 | $14.00 | $16.00 | $100.00 | S/O |
| Bank7 (BSVN) | Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | 3.33 | $18.00 | $21.00 | $64.84 | S/O |
| LAIX Inc. (LAIX) | Morgan Stanley/ Goldman Sachs (Asia) | 5.75 | $11.50 | $13.50 | $71.88 | S/O |
| Remora Royalties (RRI) | RBC Capital Markets/ Wells Fargo Securities/ UBS Investment Bank/ Stifel | 5.25 | $19.00 | $21.00 | $105.00 | S/O |
| SharedLabs (SHLB) | ThinkEquity (a division of Fordham Financial Management) | 2.50 | $5.00 | $7.00 | $15.00 | S/O |
| SVMK (SVMK) | J.P. Morgan/ Allen & Company/ BofA Merrill Lynch | 13.50 | $9.00 | $11.00 | $135.00 | S/O |
| Viomi Technology (VIOT) | Morgan Stanley/ CICC | 11.40 | $9.00 | $11.00 | $114.00 | S/O |
| X Financial (XYF) | Deutsche Bank Securities/ Morgan Stanley | 11.00 | $9.00 | $11.00 | $110.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 10, 2018 | Manager(s) | Offered | Raised | Price | 9/14/18 | Change |
| Qutoutiao (QTT) | Citigroup/ Deutsche Bank Securities | 12.00 | $84.00 | $7.00 | $15.97 | 128.14% |
| Principia Biopharma (PRNB) | BofA Merrill Lynch/ Leerink Partners/ Wells Fargo Securities | 6.25 | $106.25 | $17.00 | $32.65 | 92.06% |
| NIO Inc. (NIO) | Morgan Stanley/ Goldman Sachs (Asia)/ J.P. Morgan | 160.00 | $1,001.60 | $6.26 | $9.90 | 58.15% |
| FVCBankcorp (FVCB) | Sandler O’Neill + Partners/ Raymond James | 1.75 | $35.00 | $20.00 | $20.00 | 0.00% |
| 111, Inc. (YI) | J.P. Morgan/ Citigroup/ CICC | 7.18 | $100.45 | $14.00 | $13.99 | -0.07% |
